Fundraising FoxByers Capital — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.
BiotechDeep TechDigital HealthMedical DevicesWatertown, US
Paul L. Berns(Chairman and Chief Executive Officer)Joshua Pinto(Executive Officer)Tamara Tompkins(Executive Officer)inKari Stefansson(Director)Maykin Ho(Director)Alaa Halawa(Director)
Co-investorsARCH Venture PartnersCatalio Capital Management, LPF-Prime CapitalK2 HealthVenturesMercury FundPremier Partners+12 more
Benchling provides a cloud-based R&D platform for life sciences, combining a collaborative electronic lab notebook, structured scientific data modeling, automated workflows, and AI tools.
AI & Machine LearningBiotechEnterprise SoftwareSaaSSan Francisco, US
Sajith Wickramasekara(Founder)inAshutosh Singhal(Founder)Ashu Singhal(Founder)inCheng Kang(Founder)Cornelius Chen(Founder)
BoardMiles Grimshaw(Director)in
Co-investorsAlkeon InnovationAndreessen HorowitzArtisanal VenturesBalaji SrinivasanDraper AssociatesEnsemble Labs+31 more
Getlabs provides at-home lab sample collection, sending phlebotomists to patients to draw blood and collect samples for lab tests ordered by their providers.
Digital HealthHealthtechMedical DevicesMiami, US
Kyle Michelson(Founder)inClaire Hough(Chief Executive Officer)inMatt Bettonville(Director)David Shin(Director)Timothy Connors(Director)
Co-investorsCity LightEvolution VC PartnersPeterson VenturesRosecliff VenturesSand Hill AngelsKarlin Asset Management+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.